“The compound SR-17018 is the initial biased agonist in the mu opioid receptor that does not lead to tolerance with chronic use,” suggests Stahl, a senior staff members scientist in the Bohn lab. “This is a attractive element for likely use inside the context of chronic, intense suffering.” The authors declare that every one facts su